Guardant Health
GH
#1003
Rank
โ‚น2.297 T
Marketcap
โ‚น17,122
Share price
1.75%
Change (1 day)
206.92%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): -โ‚น320.40

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -โ‚น336.09. In 2025 the company made an earnings per share (EPS) of -โ‚น318.75 an increase over its 2024 EPS that were of -โ‚น342.83.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น320.400.52%
2025-โ‚น318.75-7.02%
2024-โ‚น342.83-16.82%
2023-โ‚น412.16-33.13%
2022-โ‚น616.3260%
2021-โ‚น385.2055.04%
2020-โ‚น248.45207.14%
2019-โ‚น80.89-19.81%
2018-โ‚น100.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-โ‚น3.46-98.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-โ‚น235.94-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA